Ginkgo biloba extract protects diabetic rats against cerebral ischemia-reperfusion injury by suppressing oxidative stress and upregulating the expression of glutamate transporter 1

The current study aimed to evaluate the neuroprotective effect of Ginkgo biloba extract (GbE) on the progression of acute cerebral ischemia-reperfusion injury in diabetic rats, and to determine the molecular mechanism associated with this effect. Streptozotocin (STZ) induced diabetic rats were pretreated with GbE (50, 100 and 200 mg/kg/day; intragastric) for 3 weeks. During this period, body weight changes and fasting blood glucose levels were assessed each week. Following pretreatment, rats were subjected to suture occlusion of the middle cerebral artery for 30 min, which was followed by 24 h of reperfusion. Neurological deficits were subsequently evaluated at 2 and 24 h following reperfusion. Rats were sacrificed after 24 h reperfusion, and infarct volume and S100B content were measured to evaluate the neuroprotective effect of GbE. The results of the present study demonstrated that GbE pretreatment improved neurological scores, and reduced cerebral infarct volume and S100B content. Oxidative stress markers, including glutathione (GSH) and superoxide dismutase (SOD) were increased, and malondialdehyde (MDA) contents were reduced following GbE treatment. The levels of p-Akt, p-mTOR and glutamate transporter 1 (GLT1) were observed to be increased in GbE-pretreated rats. These results indicated that GbE pretreatment may serve a protective role against cerebral ischemia-reperfusion injury in diabetic rats by inhibiting oxidative stress reaction, upregulating the expression of Akt/mTOR and promoting GLT1 expression. In conclusion, the current study revealed the protective role and molecular mechanisms of GbE in diabetic rats with cerebral ischemia-reperfusion injury, and may provide novel insight into the future clinical treatment of this condition.

[1]  J. Yu,et al.  Oxymatrine protects neonatal rat against hypoxic-ischemic brain damage via PI3K/Akt/GSK3β pathway. , 2020, Life sciences.

[2]  S. Dube,et al.  Isolated diastolic hypotension: A unique complication of intra-arterial nimodipine infusion!! , 2020, Journal of clinical anesthesia.

[3]  Hua-Jun Luo,et al.  Trametenolic acid B protects against cerebral ischemia and reperfusion injury through modulation of microRNA-10a and PI3K/Akt/mTOR signaling pathways. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  M. Won,et al.  Neuroprotective Effects of Gabapentin Against Cerebral Ischemia Reperfusion-Induced Neuronal Autophagic Injury via Regulation of the PI3K/Akt/mTOR Signaling Pathways , 2018, Journal of neuropathology and experimental neurology.

[5]  Zhenlong Ran,et al.  Curcumin inhibits high glucose-induced inflammatory injury in human retinal pigment epithelial cells through the ROS-PI3K/AKT/mTOR signaling pathway , 2018, Molecular medicine reports.

[6]  Zheen Aorahman Ahmed,et al.  The efficacy and safety of Ginkgo biloba extract as an adjuvant in type 2 diabetes mellitus patients ineffectively managed with metformin: a double-blind, randomized, placebo-controlled trial , 2018, Drug design, development and therapy.

[7]  Xiaoxin Yin,et al.  Antidiabetic cataract effects of GbE, rutin and quercetin are mediated by the inhibition of oxidative stress and polyol pathway. , 2017, Acta biochimica Polonica.

[8]  Jason S. Snyder,et al.  Early survival and delayed death of developmentally‐born dentate gyrus neurons , 2017, Hippocampus.

[9]  Kijeong Lee,et al.  Lenticulostriate Artery Involvement is Predictive of Poor Outcomes in Superficial Middle Cerebral Artery Territory Infarction , 2016, Yonsei medical journal.

[10]  S. Kim,et al.  Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice , 2015, International journal of medical sciences.

[11]  Xiao-Jun Ji,et al.  Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  R. Taliyan,et al.  Protective effect and mechanism of Ginkgo biloba extract-EGb 761 on STZ-induced diabetic cardiomyopathy in rats , 2014, Pharmacognosy magazine.

[13]  Liang Zhou,et al.  Upregulation of glutamate transporter GLT‐1 by mTOR‐Akt‐NF‐кB cascade in astrocytic oxygen‐glucose deprivation , 2013, Glia.

[14]  Michelle Y. Cheng,et al.  Akt Isoforms Differentially Protect against Stroke-Induced Neuronal Injury by Regulating mTOR Activities , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  K. Bae,et al.  Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells. , 2013, International journal of oncology.

[16]  H. Ou,et al.  Exercise training enhances cardiac IGFI-R/PI3K/Akt and Bcl-2 family associated pro-survival pathways in streptozotocin-induced diabetic rats. , 2013, International journal of cardiology.

[17]  P. Beart,et al.  Gene profiling identifies commonalities in neuronal pathways in excitotoxicity: Evidence favouring cell cycle re-activation in concert with oxidative stress , 2013, Neurochemistry International.

[18]  Qianming Chen,et al.  Magnolol Protects Against Oxidative Stress-Mediated Neural Cell Damage by Modulating Mitochondrial Dysfunction and PI3K/Akt Signaling , 2013, Journal of Molecular Neuroscience.

[19]  Shaohui Wang,et al.  Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade , 2012, International journal of molecular sciences.

[20]  A. Kabanov,et al.  Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[21]  N. Wilczak,et al.  GFAP and S100B in the acute phase of mild traumatic brain injury , 2012, Neurology.

[22]  Yao-Wu Liu,et al.  Ginsenoside Re attenuates diabetes-associated cognitive deficits in rats , 2012, Pharmacology Biochemistry and Behavior.

[23]  L. Kappelle,et al.  Diabetes, hyperglycaemia, and acute ischaemic stroke , 2012, The Lancet Neurology.

[24]  Gang Li,et al.  High glucose-induced expression of inflammatory cytokines and reactive oxygen species in cultured astrocytes , 2012, Neuroscience.

[25]  J. Klein,et al.  Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain. , 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[26]  M. Tymianski.  Emerging mechanisms of disrupted cellular signaling in brain ischemia , 2011, Nature Neuroscience.

[27]  Yunman Li,et al.  Maslinic acid, a natural inhibitor of glycogen phosphorylase, reduces cerebral ischemic injury in hyperglycemic rats by GLT‐1 up‐regulation , 2011, Journal of neuroscience research.

[28]  J. Rothstein,et al.  Nuclear Factor-κB Contributes to Neuron-Dependent Induction of Glutamate Transporter-1 Expression in Astrocytes , 2011, The Journal of Neuroscience.

[29]  J. Danesh,et al.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.

[30]  Jialing Wu,et al.  Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. , 2010, The Journal of clinical investigation.

[31]  V. Demarin,et al.  Assessment of subtle cognitive impairment in stroke-free patients with carotid disease. , 2009, Acta clinica Croatica.

[32]  Noo Li Jeon,et al.  Presynaptic Regulation of Astroglial Excitatory Neurotransmitter Transporter GLT1 , 2009, Neuron.

[33]  B. Hemmings,et al.  The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death , 2009, Nature Neuroscience.

[34]  P. Koh.  Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway , 2008, Neuroscience Letters.

[35]  P. Fu,et al.  Ginkgo Biloba Leave Extract: Biological, Medicinal, and Toxicological Effects , 2007, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[36]  H. Steinmetz,et al.  Elevated Serum S100B Levels Indicate a Higher Risk of Hemorrhagic Transformation After Thrombolytic Therapy in Acute Stroke , 2007 .

[37]  R. Giffard,et al.  Selective Dysfunction of Hippocampal CA1 Astrocytes Contributes to Delayed Neuronal Damage after Transient Forebrain Ischemia , 2007, The Journal of Neuroscience.

[38]  Mathias Hoehn,et al.  Temporal profile of T2-Weighted MRI Distinguishes between Pannecrosis and Selective Neuronal Death after Transient Focal Cerebral Ischemia in the Rat , 2006, Journal of Cerebral Blood Flow and Metabolism.

[39]  V. Salomaa,et al.  Diabetes worsens the outcome of acute ischemic stroke. , 2005, Diabetes research and clinical practice.

[40]  J. Rafols,et al.  Cerebral ischemia induced apoptosis and necrosis in normal and diabetic rats , 2005, Brain Research.

[41]  J. Alger,et al.  Evolving Paradigms in Neuroimaging of the Ischemic Penumbra , 2004, Stroke.

[42]  Henrik Vestergaard,et al.  The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. , 2004, Archives of internal medicine.

[43]  Antonio Ceriello,et al.  Oxidative Stress in Diabetes , 2003, Clinical chemistry and laboratory medicine.

[44]  V. Arolt,et al.  S100B in brain damage and neurodegeneration , 2003, Microscopy research and technique.

[45]  K. Csiszȧr,et al.  Diabetes activates cell death pathway after transient focal cerebral ischemia. , 2003, Diabetes.

[46]  J. Schulte‐Mönting,et al.  Hyperglycemia in Patients with Focal Cerebral Ischemia after Intravenous Thrombolysis: Influence on Clinical Outcome and Infarct Size , 2002, Cerebrovascular Diseases.

[47]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[48]  N. Danbolt.  Glutamate uptake , 2001, Progress in Neurobiology.

[49]  J. Rothstein,et al.  Antisense Knockdown of the Glial Glutamate Transporter GLT-1, But Not the Neuronal Glutamate Transporter EAAC1, Exacerbates Transient Focal Cerebral Ischemia-Induced Neuronal Damage in Rat Brain , 2001, The Journal of Neuroscience.

[50]  I. Meineke,et al.  Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[51]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[52]  A. Shuaib,et al.  Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method , 1998, Journal of Neuroscience Methods.

[53]  A. Volterra,et al.  Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? , 1998, Trends in pharmacological sciences.

[54]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[55]  E. Barrett-Connor,et al.  Diabetes mellitus: an independent risk factor for stroke? , 1988, American journal of epidemiology.

[56]  Y. Sun,et al.  A simple method for clinical assay of superoxide dismutase. , 1988, Clinical chemistry.

[57]  Xiaofeng Wu,et al.  Title PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes , 2017 .

[58]  Dhiren P. Shah,et al.  ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS , 2013 .

[59]  L. Luo,et al.  Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. , 2012, International immunopharmacology.

[60]  G. Superti-Furga,et al.  Complement factor H binds malondialdehyde epitopes and protects from oxidative stress , 2011, Nature.

[61]  R. M. Adibhatla,et al.  Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. , 2010, Antioxidants & redox signaling.

[62]  A. Camacho,et al.  Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. , 2006, Archives of medical research.

[63]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.